GeneDx Holdings Corp. (WGS) — Cash Flow Reinvestment Rate
GeneDx Holdings Corp. (WGS) has a Cash Flow Reinvestment Rate of 0.69x as of September 2025, reinvesting $10.86 Million (capex $6.17 Million plus investments $-4.69 Million) from operating cash flow of $15.77 Million. See GeneDx Holdings Corp. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GeneDx Holdings Corp. Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for GeneDx Holdings Corp. across 1 annual periods. For the full cash flow conversion analysis, see GeneDx Holdings Corp. operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for GeneDx Holdings Corp. (2025–2025)
Year-by-year capital reinvestment analysis for GeneDx Holdings Corp.. See WGS financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.86x | $28.66 Million | $33.28 Million | $19.02 Million | — |